Search - tctmd.com

Displaying 501 - 520 of 535

Sort: Relevancy | Date

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

News Daily News

TROFI Published: No Clear Benefit of Thrombectomy in STEMI Patients Undergoing PCI

L.A. McKeown

February 12, 2013

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Conference News ESC 2012

STEMI Patient Population Evolves Over 15 Years

Yael L. Maxwell

August 27, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Daily News

Small Study Supports Safety of Radial PCI in STEMI Patients

L.A. McKeown

August 07, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

Advertisement

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Remote Postconditioning Reduces AKI in NSTEMI Patients

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

TROFI Published: No Clear Benefit of Thrombectomy in STEMI Patients Undergoing PCI

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

STEMI Patient Population Evolves Over 15 Years

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Small Study Supports Safety of Radial PCI in STEMI Patients

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

More Than Half of Readmissions Within 30 Days of Acute MI Unrelated to Index Event

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content